Bovex 2.265%
Bovex 2.265%
Authorised
- Oxfendazole
Product identification
Medicine name:
Bovex 2.265%
Active substance:
- Oxfendazole
Target species:
-
Cattle
-
Sheep
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Oxfendazole2.27/gram(s)100.00millilitre(s)
Pharmaceutical form:
-
Oral suspension
Withdrawal period by route of administration:
-
Oral use
- Cattle
-
Meat and offal14day
-
Milk84hour
-
- Sheep
-
Meat and offal21day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AC02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Ireland
Package description:
- 10 litre high density polyethylene containers and closures.
- 5 litre high density polyethylene containers and closures.
- 2.5 litre high density polyethylene containers and closures.
- 1 litre high density polyethylene containers and closures.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Informed consent (abridged application) - Council Directive 81/851/EEC
Marketing authorisation holder:
- Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
- HPRA
Authorisation number:
- VPA10987/039/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 8/04/2022
How useful was this page?:
